Quote:

---

Not sure if they ever disclosed receptor occupancy versus dosage or LL concentration curve, have they?

---

Quote:

---

Finally, we extended these results to Leronlimab-treated humans and found that weekly 700 mg Leronlimab led to complete CCR5 RO on peripheral blood CD4+ T cells and a statistically significant increase in CCR5+CD4+ T cells in peripheral blood.
https://pubmed.ncbi.nlm.nih.gov/34868084/

---

Quote:

---

We observed complete CCR5 receptor occupancy in all donors by day 7.https://www.ijidonline.com/article/S1201-9712(20)32305-5/pdf

---

Until 2019 there wasn't a sensitive enough test to accurately determine CCR5 receptor occupancy. Patterson developed a flow cytometry one for Cytodyn.